Clinical trial · Interventional
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy: A Pilot Feasibility Clinical Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
New oral anticancer treatments have improved survival across cancer types but introduced challenges in medication adherence and symptom management. The SMART pilot trial will test a new mobile health intervention that facilitates remote adherence and symptom monitoring, patient-provider communication outside of clinic visits regarding the use of oral anticancer treatments, and support for financial and social needs, as well as health literacy support, for 30 English- and Spanish-speaking patients. This study will increase understanding of barriers and facilitators to the use of the proposed mHealth intervention.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Neoplasms | Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SMART Intervention using TAPPT® for Adherence, Symptom, Financial, and Social Needs Monitoring | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- SMART Intervention Arm
- description
- Participants receive the SMART intervention, a multi-level mobile health program using TAPPT® smart labels and a web-based app for real-time OAT adherence tracking. SMART includes personalized text reminders, biweekly symptom and adherence surveys, management of missed or extra doses through oncology alerts, management of symptoms through oncology alerts or educational resources, monthly screening and support for financial and health-related social needs, and tailored educational messages for participants with low health literacy. All participants receive usual oncology care in addition to the SMART intervention.
- interventionNames
- Behavioral: SMART Intervention using TAPPT® for Adherence, Symptom, Financial, and Social Needs Monitoring
Primary outcomes (2)
- measure
- Feasibility of the SMART Intervention
- timeFrame
- 3 months from intervention initiation
- description
- Feasibility will be assessed by the proportion of participants using TAPPT® adherence monitoring for the duration of therapy and the proportion completing all available biweekly surveys.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Must speak English or Spanish * Must be 18 years of age or older * Have a diagnosis of any type and stage of cancer * Have a new prescription for an oral anticancer therapy (OAT) initiated within the last 90 days or planned to start within the next 15 days * Be receiving treatment at UCI Chao Family Comprehensive Cancer Center-affiliated oncology clinics * Own a smartphone and be willing to receive study-related text messages. Exclusion Criteria: * Have an Eastern Cooperative Oncology Group (ECOG) performance status greater than 2 * Be medically or cognitively unable to give consent or participate in the study * Be participating in another clinical trial that monitors adherence or symptoms related to the newly prescribed OAT
References
Publications (0)
Data not yet available